MoneyWorks4Me

Solara Active Pharma Sciences inks pact with SeQuent Scientific

24 Sep 2018 Evaluate

Solara Active Pharma Sciences has entered into a business transfer agreement with SeQuent Scientific for sale of API facility at Mahad. The total consideration for the unit would be Rs 46.40 crore. The company has decided to hive-off Mahad unit as it is not aligned to multi product and US focused business of the company.

Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer.

Peers
Company Name CMP
Sun Pharma. Inds. 1848.00
Dr. Reddys Labs. 1198.65
Cipla 1408.75
Lupin 2084.00
Zydus Lifesciences 1190.50
View more..